PEPTIDE ALS INHIBITOREN DER NS3-SERINPROTEASE DES HEPATITIS C VIRUS

The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associ...

Full description

Saved in:
Bibliographic Details
Main Authors SANTHANAM, BAMA, TAMURA, SUSAN Y, ARASAPPAN, ASHOK, BOGEN, STEPHANE, PAREKH, TEJAL, LIM-WILBY, MARGUERITA, VENKATRAMAN, SRIKANTH, PINTO, PATRICK A, GANGULY, ASHIT, LIU, YI-TSUNG, CHEN, KEVIN, GIRIJAVALLABHAN, VIYYOOR, WANG, HAIYAN, NJOROGE, F, WU, WANLI, VACCARO, HENRY, LEVY, ODILE ESTHER, JAO, EDWIN, SAKSENA, ANIL, LOVEY, RAYMOND, PIKE, RUSSELL, BENNETT, FRANK, HUANG, YUHUA, KEMP, SCOTT JEFFREY, CHAN, TIN-YAU, HENDRATA, SISKA, ZHU, ZHAONING, MC CORMICK, JINPING
Format Patent
LanguageGerman
Published 15.04.2010
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
Bibliography:Application Number: AT20010954764T